Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study) : A multicentre, randomised, double-blinded, placebo-controlled trial
Citation
Landman , A J E M C , de Boer , M A , Visser , L , Nijman , T A J , Hemels , M A C , Naaktgeboren , C N , van der Weide , M C , Mol , B W , van Laar , J O E H , Papatsonis , D N M , Bekker , M N , van Drongelen , J , van Pampus , M G , Sueters , M , van der Ham , D P , Sikkema , J M , Zwart , J J , Huisjes , A J M , van Huizen , M E , Kleiverda , G , Boon , J , Franssen , M T M , Hermes , W , Visser , H , de Groot , C J M & Oudijk , M A 2022 , ' Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study) : A multicentre, randomised, double-blinded, placebo-controlled trial ' , PLoS Medicine , vol. 19 , no. 2 , e1003892 . https://doi.org/10.1371/journal.pmed.1003892
Rights
Copyright: © 2022 Landman et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. https://creativecommons.org/licenses/by/4.0/